Atlas Trials

Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders

Clinical trial NCT02411123 · COMPLETED

Trial details

NCT number
NCT02411123
Sponsor
AltheaDx
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
DepressionAnxiety
Start date
2015-03-01
Primary completion
2015-10-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.